A mutation in SLC20A2 (c.C1849T) promotes proliferation while inhibiting hypertrophic differentiation in ATDC5

YiQiang Li1, XueMei Lin1, MingWei Zhu1

  • 1Department of Pediatric Orthopaedics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Bone & Joint Research
|November 2, 2020
PubMed
Abstract

Insights

A mutation in the solute carrier family 20 member 2 (SLC20A2) gene impairs phosphate uptake in chondrocytes. This SLC20A2 mutation increases cell proliferation but reduces differentiation, potentially involving the Ihh/PTHrP pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Hereditary multiple exostoses is linked to genetic mutations.
  • Solute carrier family 20 member 2 (SLC20A2) plays a role in phosphate transport.
  • Understanding SLC20A2's function is crucial for bone development disorders.

Purpose of the Study:

  • To investigate the impact of an SLC20A2 gene mutation on chondrocyte proliferation and differentiation.
  • To analyze the role of the Indian hedgehog (Ihh) and parathyroid hormone-related protein (PTHrP) signaling pathway.

Main Methods:

  • ATDC5 chondrocytes were cultured and induced to differentiate.
  • Cells were transfected with wild-type (WT) or mutated (MUT) SLC20A2.
  • Phosphate uptake, gene/protein expression (qRT-PCR, Western blotting), and pathway activity were assessed.

Main Results:

  • The SLC20A2 mutation significantly reduced phosphate uptake in chondrocytes.
  • Chondrocyte proliferation increased, while differentiation markers (e.g., Acan, COL2A1, SOX9) were upregulated, and terminal differentiation markers (e.g., Runx2, COL10A1, MMP13) were downregulated.
  • The Ihh/PTHrP pathway was upregulated in the MUT group and its inhibition restored normal chondrocyte function.

Conclusions:

  • A specific SLC20A2 mutation (c.C1948T) impairs phosphate transport in chondrocytes.
  • This mutation promotes chondrocyte proliferation and inhibits differentiation.
  • The Ihh/PTHrP signaling pathway is implicated in the observed effects of the SLC20A2 mutation.